Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
Authors
Keywords
-
Journal
CANCER
Volume 122, Issue 5, Pages 766-772
Publisher
Wiley
Online
2015-12-23
DOI
10.1002/cncr.29812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
- (2015) Oscar Arrieta et al. Journal of Thoracic Oncology
- Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer
- (2015) Aliccia Bollig-Fischer et al. Journal of Thoracic Oncology
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- EGFRMutations in US Hispanic Versus Non-Hispanic White Patients With Lung Adenocarcinoma
- (2013) Wei Zhang et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice
- (2013) Norihiro Yamaguchi et al. LUNG CANCER
- Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist?
- (2013) Joshua Bauml et al. LUNG CANCER
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer
- (2011) Michele L. Cote et al. Journal of Thoracic Oncology
- Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America
- (2011) Oscar Arrieta et al. Journal of Thoracic Oncology
- Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans
- (2010) J. Matthew Reinersman et al. Journal of Thoracic Oncology
- Genetic Abnormalities of theEGFRPathway in African American Patients With Non–Small-Cell Lung Cancer
- (2009) Rom S. Leidner et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started